Skip to main content
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. — Investor Relations & Filings

Ticker · IDYA ISIN · US45166A1025 LEI · 549300ULW08F62IJML11 US Manufacturing
Open in API
Filings indexed 466 across all filing types
Latest filing 2020-02-14 Major Shareholding Noti…
Country US United States of America
Listing US IDYA

About IDEAYA Biosciences, Inc.

https://www.ideayabio.com/

IDEAYA Biosciences, Inc. is a clinical-stage precision medicine oncology company focused on the discovery, development, and commercialization of targeted therapeutics for cancer. The company's primary scientific approach is synthetic lethality, an emerging class of precision medicine that targets cancer cells based on specific genetic alterations. IDEAYA develops potential first-in-class and best-in-class therapies for patient populations selected using molecular diagnostics. Its integrated platform combines capabilities in target and biomarker discovery with the development of small molecule and protein degrader therapeutics to address unmet needs in cancer treatment.

Recent filings

Filing Released Lang Actions
AMENDMENT NO. 1 TO THE SCHEDULE 13G
Major Shareholding Notification
2020-02-14 English
SC 13G
Major Shareholding Notification
2020-02-13 English
SC 13G
Major Shareholding Notification
2020-02-06 English
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated January 13, 2020, by IDEAYA Biosciences, Inc. It announces the use of a new corporate presentation which is attached as Exhibit 99.1. The text explicitly states that the presentation is being furnished and is not considered "filed" for purposes of Section 18 of the Exchange Act, indicating this is an announcement of a presentation rather than the presentation itself. The document length is 3477 characters, which is relatively short and consistent with an announcement rather than a full report. The key phrase "Corporate Presentation" and the context of the filing under Item 7.01 Regulation FD Disclosure confirm this is an investor presentation announcement. Therefore, the appropriate classification is Investor Presentation (IP).
2020-01-13 English
FORM 4
Director's Dealing
2019-12-20 English
FORM 4
Director's Dealing
2019-12-20 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.